Supplementary Table S1-S6 from Chemically Modified Antisense Oligonucleotide Against ARL4C Inhibits Primary and Metastatic Liver Tumor Growth

The sequences of ARL4C ASOs (Table S1), primers (Table S2) and siRNA (Table S3). Relationship between ARL4C expression and clinicopathological facrors of HCC and CRC cases (Table S4). Univariate analysis of relapse-free survival of HCC and CRC (Table S5). mRNA levels of candidate off-target genes for ARL4C ASO (Table S6).